Current Trends in the Management of Gastroesophageal Reflux Disease

키워드

참고문헌 (57)

1. Katz PO, "Guidelines for the diagnosis and management of gastroesophageal reflux disease", Am J Gastroenterol, 108, pp.308~328 (2013)[DOI]
2. Fass R, "Gastroesophageal reflux disease: should we adopt a new conceptual framework?", Am J Gastroenterol, 97, pp.1901~1909 (2002)
3. El-Serag HB, "Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review", Gut, 63, pp.871~880 (2014)[DOI]
4. Nasrollah L, "Naps are associated more commonly with gastroesophageal reflux, compared with nocturnal sleep", Clin Gastroenterol Hepatol, 13, pp.94~99 (2015)[DOI]
5. Fass R, "Non-erosive reflux disease (NERD) and erosive esophagitis: a spectrum of disease or special entities?", Z Gastroenterol, 45, pp.1156~1163 (2007)[DOI]
6. Poh CH, "Review: treatment of gastroesophageal reflux disease in the elderly", Am J Med, 123, pp.496~501 (2010)[DOI]
7. Kaltenbach T, "Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach", Arch Intern Med, 166, pp.965~971 (2006)[DOI]
8. Jacobson BC, "Body-mass index and symptoms of gastroesophageal reflux in women", N Engl J Med, 354, pp.2340~2348 (2006)[DOI]
9. Fass R, "The relationship between gastroesophageal reflux disease and sleep", Curr Gastroenterol Rep, 11, pp.202~208 (2009)[DOI]
10. Fujiwara Y, "Gastroesophageal reflux disease and sleep disturbances", J Gastroenterol, 47, pp.760~769 (2012)[DOI]
11. Chey WD, "Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement?", Dig Dis Sci, 55, pp.3415~3422 (2010)[DOI]
12. Dean BB, "Effectiveness of proton pump inhibitors in nonerosive reflux disease", Clin Gastroenterol Hepatol, 2, pp.656~664 (2004)[DOI]
13. Chiba N, "Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis", Gastroenterology, 112, pp.1798~1810 (1997)[DOI]
14. Zhang JX, "Proton pump inhibitor for non-erosive reflux disease: a meta-analysis", World J Gastroenterol, 19, pp.8408~8419 (2013)[DOI]
15. Khan M, "Medical treatments in the short term management of reflux oesophagitis", Cochrane Database Syst Rev, (2) (2007)
16. Sigterman KE, "Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease", Cochrane Database Syst Rev, (5) (2013)
17. Caro JJ, "Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials", Clin Ther, 23, pp.998~1017 (2001)[DOI]
18. Gralnek IM, "Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials", Clin Gastroenterol Hepatol, 4, pp.1452~1458 (2006)[DOI]
19. Fass R, "Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release", Clin Gastroenterol Hepatol, 10, pp.247~253 (2012)[DOI]
20. van Zanten SJ, "Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review", Can J Gastroenterol, 26, pp.196~204 (2012)[DOI]
21. Jiang YX, "Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis", Hepatogastroenterology, 60, pp.1077~1082 (2013)
22. Compher C, "Efficacy vs effectiveness", JPEN J Parenter Enteral Nutr, 34, pp.598~599 (2010)[DOI]
23. El-Serag HB, "Efficacy, effectiveness, and comparative effectiveness in liver disease", Hepatology, 52, pp.403~407 (2010)[DOI]
24. Hershcovici T, "Step-by-step management of refractory gastresophageal reflux disease", Dis Esophagus, 26, pp.27~36 (2013)[DOI]
25. Sheikh I, "Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease", Am J Gastroenterol, 109, pp.789~794 (2014)[DOI]
26. Gunaratnam NT, "Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease", Aliment Pharmacol Ther, 23, pp.1473~1477 (2006)[DOI]
27. Sugimoto M, "Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype", Aliment Pharmacol Ther, 36, pp.627~634 (2012)[DOI]
28. Fass R, "Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study", Aliment Pharmacol Ther, 14, pp.1595~1603 (2000)[DOI]
29. Richter JE, "Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group", Am J Gastroenterol, 95, pp.3071~3080 (2000)[DOI]
30. Hetzel DJ, "Healing and relapse of severe peptic esophagitis after treatment with omeprazole", Gastroenterology, 95, pp.903~912 (1988)[DOI]
31. Fass R, "Therapeutic options for refractory gastroesophageal reflux disease", J Gastroenterol Hepatol, 27(Suppl 3), pp.3~7 (2012)
32. Herregods TV, "Patients with refractory reflux symptoms often do not have GERD", Neurogastroenterol Motil, 27, pp.1267~1273 (2015)[DOI]
33. Fass R, "Management of heartburn not responding to proton pump inhibitors", Gut, 58, pp.295~309 (2009)[DOI]
34. Tiberiu Hershcovici, "Nonerosive Reflux Disease (NERD) - An Update", Journal of Neurogastroenterology and Motility (JNM), 16(1), pp.8~21 (2010), 대한소화기 기능성질환∙운동학회
35. Fackler WK, "Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough", Gastroenterology, 122, pp.625~632 (2002)[DOI]
36. Grossi L, "Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study", Neurogastroenterol Motil, 20, pp.760~766 (2008)[DOI]
37. Koek GH, "Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors", Gut, 52, pp.1397~1402 (2003)[DOI]
38. Li S, "The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials", Gastroenterol Res Pract, 2014, pp.307805~ (2014)
39. Hershcovici T, "Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors", Curr Opin Gastroenterol, 26, pp.367~378 (2010)[DOI]
40. Lazarus B, "Proton pump inhibitor use and the risk of chronic kidney disease", JAMA Intern Med, 176, pp.238~246 (2016)[DOI]
41. Gomm W, "Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis", JAMA Neurol, 73, pp.410~416 (2016)[DOI]
42. Khan F, "Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013", Aliment Pharmacol Ther, 43, pp.1124~1131 (2016)[DOI]
43. Broeders JA, "Laparoscopic anterior versus posterior fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials", Ann Surg, 254, pp.39~47 (2011)[DOI]
44. Memon MA, "Laparoscopic anterior versus posterior fundoplication for gastro-esophageal reflux disease: a meta-analysis and systematic review", World J Surg, 39, pp.981~996 (2015)[DOI]
45. Rickenbacher N, "Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis", Surg Endosc, 28, pp.143~155 (2014)[DOI]
46. Garg SK, "Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults", Cochrane Database Syst Rev, (11) (2015)
47. Hatlebakk JG, "Gastroesophageal acid reflux control 5 years after antireflux surgery, compared with long-term esomeprazole therapy", Clin Gastroenterol Hepatol, 14, pp.678~685 (2016)[DOI]
48. Ganz RA, "Esophageal sphincter device for gastroesophageal reflux disease", N Engl J Med, 368, pp.719~727 (2013)[DOI]
49. Warren HF, "Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease", Surg Endosc, 30, pp.3289~3296 (2016)[DOI]
50. Hakansson B, "Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD", Aliment Pharmacol Ther, 42, pp.1261~1270 (2015)[DOI]
51. Trad KS, "Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial", Surg Innov, 22, pp.26~40 (2015)[DOI]
52. Trad KS, "Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study", BMC Gastroenterol, 14, pp.174~ (2014)[DOI]
53. Testoni PA, "Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study", Surg Endosc, 29, pp.2770~2780 (2015)[DOI]
54. Hunter JG, "Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial", Gastroenterology, 148, pp.324~333 (2015)[DOI]
55. Richards WO, "Initial experience with the stretta procedure for the treatment of gastroesophageal reflux disease", J Laparoendosc Adv Surg Tech A, 11, pp.267~273 (2001)[DOI]
56. Lipka S, "No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 13, pp.1058~1067 (2015)[DOI]
57. Noar M, "Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later", Surg Endosc, 28, pp.2323~2333 (2014)[DOI]

관련 논문AI추천